✦ LIBER ✦

Intralesional injections of Citoprot-P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

✍ Scribed by José I Fernández-Montequín; Ena Infante-Cristiá; Carmen Valenzuela-Silva; Neobalis Franco-Pérez; William Savigne-Gutierrez; Heriberto Artaza-Sanz; Lourdes Morejón-Vega; Cecilio González-Benavides; Osvaldo Eliseo-Musenden; Elizeth García-Iglesias; Jorge Berlanga-Acosta; Ricardo Silva-Rodríguez; Blas Y Betancourt; Pedro A López-Saura; Cuban Citoprot-P Study Group

Book ID: 111314477
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 408 KB
Volume: 0
Category: Article
ISSN: 1742-4801
DOI: 10.1111/j.1742-481x.2007.00344.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intralesional injections of Citoprot-P®

Intralesional injections of Citoprot-P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

Unexpected complication of intralesional

Unexpected complication of intralesional injection of recombinant human epidermal growth factor: diabetic foot osteomyelitis

✍ Ersen, Omer; Kara, Kemal; Memis, Ali; Mutluoglu, Mesut; Ay, Hakan 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Active post-marketing surveillance of th

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

✍ Yera-Alos, Isis B; Alonso-Carbonell, Liuba; Valenzuela-Silva, Carmen M; Tuero-Ig 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 293 KB

Efficacy of intralesional recombinant hu

Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial

✍ Gomez-Villa, Ramiro; Aguilar-Rebolledo, Francisco; Lozano-Platonoff, Adriana; Te 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Cost-Effectiveness of Intralesional Inje

Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting

✍ Ignatyeva, V.; Avxentyeva, M.; Galstyan, G.R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Intra-lesional injections of recombinant

Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study

✍ José I Fernández-Montequín; Carmen M Valenzuela-Silva; Odalys González Díaz; Wil 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB